Strains of Klebsiella spp. are often inagglutinable by 0-specific antisera because of the copious capsule produced by most isolates. A competitive ELISA method based on the observation that bacterial supernates containing homologous 0 antigen specifically inhibited the reaction of typespecific antisera with purified LPS coated on ELISA plates was used to examine the 0 antigen of 82 isolates of different Klebsiella species and subspecies. The 0 antigens 01/2ab (19 isolates), 02ab (13 isolates), 02ac (11 isolates) and 0 3 (16 isolates) were found to account for > 70% of the 0 antigenic types. Overall, 65 (79%) of the strains could be assigned to a specific 0 serogroup. The method is suitable for examining the role of individual 0 antigens in systemic klebsiella infections such as nosocomial septicaemia and pneumonia.
Introduction
Organisms of the genus Klebsiella are a frequent cause of nosocomial infections including pneumonia [ 11, septicaemia [l-31, and urinary tract infections [l, 41. In bacteraemic gram-negative infections, klebsiellae usually rank second only to Escherichia coli and are isolated more frequently than Pseudomonas aeruginosa [3, 5] . However, in contrast to the latter two pathogens, whose somatic antigens have been studied extensively both with respect to pathogenicity and their possible role as a target for immunotherapy [6-91, relatively little attention has been paid to such issues in Klebsiella spp. Because the presence of a large capsule is the most prominent feature of Klebsielh isolates, most investigators have focused on the role of the capsule as a virulence factor and on the distribution of capsular types in clinical material [ 10-141. More recently, it has been recognised that the somatic lipopolysaccharide (LPS, 0 antigen) produced by Klebsiella spp. may also play an important role in the pathogenesis of blood stream [15, 161 and pulmonary infection [17] by this organism. While the latter observations have been made for strains of serotype 0 1 which occur most frequently in clinical material [18-211, little is known about the occurrence and pathogenic potential of strains with other 0 antigens.
During the last five decades, 12 Klebsiella 0 antigen serogroups have been described. However, subsequent examinations revealed that four of these, namely 06, 08, 0 9 and 011, were identical with, or closely related to, others described previously [22- 261. Serogroup 010 was deleted after it was found that the respective prototype strain was motile and, therefore, had to be relocated to the genus Enterobacter [22] . At present, serogroups 01-05, 0 7 and 012 are recognised as being clearly distinct [27] . Within serogroup 02, 0rskov identified eight subgroups all of which shared a common "2a" antigen [18] . Recently, it has been shown that the 0 1 antigen comprises two different specificities one of which, termed D-galactan I, appears to be serologically identical to the 02a antigen [28] . Thus, the correct designation for this 0 antigen may be 01/2a.
In a previous report describing a monoclonal antibody against LPS of Klebsiella, we also studied the relative importance of 0 serogroups of Klebsiella other than 0 1 in clinical material [29] . In this study, a competitive ELISA method which enables the reliable identification of the 0 antigen in clinical isolates of Klebsiella is described in more detail. This method may serve as a tool for further, more extensive studies, which may characterise the importance of individual 0 antigens in defined clinical settings such as septicaemia and pneumonia. If relatively few 0 antigens are found in a significant portion of clinical isolates from cases of invasive disease, then an 0 antigen-based polyvalent vaccine may be feasible for the immunotherapy or prophylaxis of klebsiella infection.
Materials and methods

Bacteria
The Klebsiella 0 antigen reference strains Klebsiella Friedliinder 201 (01 :K-), 7380 (02ab:K-), 5053 (02ac:K-), 390 (03:Kl l), 1702 (04:K42), 442551 (05:K57), 264(1) (07:K67) and 708 (012:K80), and additional strains harbouring homologous 0 antigens namely Klebsiella 2002/49 (03:K25), Mich. 61 (04:K15), 5710/52 (05K61) and E. coli 8188/41 (019a,19b) whose 0 antigen has been shown to be serologically identical to Klebsiella 0 1 [30] were obtained from Drs I. and F. Qlrskov, International Klebsiella and E. coli Reference Centre, Statens Senuninstitut, Copenhagen, Denmark. The 0 antigen of E. coli Bort (018:H7:Kl) which has been used previously in our laboratories [31] was found not to be related to any known Klebsiella 0 antigen. Therefore, this strain was included as a negative control in all serological studies. Clinical isolates of K. pneumoniae and K. oxytoca were collected in the Department of Medical Microbiology, University of Ulm, and identified by the API 20E system. Additional biochemical tests were performed as described previously [32] . K. tewigena [33] , K, ozaenae and K. rhinoscleromatis strains were from the collection of the Department of Medical Microbiology, University of Kiel, Germany.
Additional strains included were K. ozaenae NCTC 9657, NCTC 5050, NCTC 5051; K. rhinoscleromatis NCTC 1936, NCTC 5046 and ATCC 9436.
Lipopolysaccharides
The hot phenol-water method [34] was used to prepare lipopolysaccharides from all 0 antigen reference strains, E. coli 8188/41 and E. coli Bort. Capsular material was removed by precipitation with cetylmethylammoniumbromide (Cetavlon, Merck, Darmstadt, Germany) 1.25% as described previously [35] . Final LPS preparations were examined for protein by determination of the absorbance (A) at 280nm and for the presence of residual capsular polysaccharide (CPS) by the determination of glucuronic acid [36] .
Production of antisera
Outbred rabbits were immunised with the Klebsiella 0 antigen reference strains, additional Klebsiella strains possessing known 0 antigens, and with E. coli 81881 41. Bacteria used for immunisation were grown in trypticase soy broth at 37°C for 4-5 h, washed twice in physiological saline and adjusted in saline to give suspensions containing 1 X 1 O8 c Wml. Non-capsulate organisms were inactivated at 60°C for 1 h. Capsulate strains were boiled for 2 h to destroy the K antigens.
Suspensions were stabilised by the addition of formalin 0.5% and kept at 4°C. Rabbits (mean weight 3.5 kg) were immunised intravenously into the ear vein with the following volumes of bacterial suspension: 0.2 ml (day 0), 0.5ml (day 5), 1.0ml (day lo), 1.5ml (day 15), 2.0 ml (day 20). Seven days later, 30-50 ml of venous blood were taken from each rabbit and, after centrifugation, the serum was removed and stored.
Because klebsiellae are known to possess common 0 antigen epitopes [29] and, possibly, common protein antigens, sera were absorbed with the heterologous 0 antigen reference strains. For this purpose, 40ml of serum were mixed thoroughly with a bacterial pellet containing c. lo9 cells and incubated on crushed ice for 1 h with repeated vortex mixing. The suspension was then centrifuged and the supernatant serum was absorbed three more times in the same manner.
Final serum supernates were filter-sterilised (0.45 ppore Millex HA filter unit; Millipore, Molsheim, France) and frozen in 1-ml volumes at -25°C or lyophilised.
Direct ELISA
To determine the titre of 0-specific antisera, 96-well flat-bottomed microtitration plates (Greiner, Niirtingen, Germany) were coated (100 pl/well) with purified LPS 25 pg/ml in PBS, pH 7.4. After incubation at 4°C for 18 h and removal of antigen, 200 pl of "filling-buffer" (PBS, pH 7.4, containing bovine serum albumin 0.5%, casein 0.5% and sodium azide 0.1%) were added to each well to block non-specific binding sites. After incubation for 1 h at 37"C, plates were washed three times with PBS. Two-fold dilutions of 0-specific antisera in "filling buffer'' were added to duplicate wells (100 pl/well) and incubated overnight at 4°C. The plates were then washed three times with PBS, and 100 pl of appropriately diluted alkaline phosphataseconjugated anti rabbit-IgG(y) monoclonal antibody (Sigma) were added to each well. After incubation at 4°C for 4 h, the plates were washed and reactions were developed by adding to each well 200p1 of substrate solution (p-nitrophenyl phosphate 1 mg/ml in 1 M diethanolamine buffer, pH 9.8). The OD405 of the wells was read in a Titertek Multiscan Plus reader (Flow Laboratories, Helsinki, Finland) after incubation for 30 min. Titres were defined as the highest dilution of antiserum yielding a mean OD405 2 0.300.
Competitive ELISA
Optimal serum dilutions and coating conditions for the competitive ELISA were selected on the basis of chessboard titrations with LPS concentrations from 0.5 to 32 pg/ml and serum dilutions from 100 to 5 1 200. In preliminary experiments, it was found that an OD405 of 0.3-0.4 obtained without inhibition provided optimum sensitivity for competition, resulting in OD405 values near to 0 after inhibition with homologous supernates.
Klebsiella strains to be tested were grown overnight on trypticase soy agar, suspended at a density of c. lo9 celldm1 in PBS, pH 7.4, and boiled for 2 h to destroy most of the capsular material and proteins and to release membrane-bound LPS. After centrifugation (4000 g , 30 min) the clear supernates containing soluble LPS were harvested and stored at 4°C. For ELISA inhibition, 150 pl of appropriately diluted 0-specific antiserum were mixed with 150 p1 of boiled bacterial supernate and vortex mixed every 15 min during incubation for 2 h on crushed ice. Inhibition mixtures were pipetted ( 100 puVwel1) into duplicate wells of LPS-coated microtitration plates and incubated at 4°C for 18 h. After removal of the mixture and washing, the plates were processed further as described for the direct ELISA. Each plate contained a positive control (supernate of the 0 reference strain harbouring the same 0 antigen coated on the plate) and a negative control (supernate of E. coli Bort). Developing times for each plate were adjusted to yield a mean OD405 of 0.3-0.4 for the negative control.
Results
Purity of LPS preparations
The protein content of all LPS preparations was < 1% of dry weight. The glucuronic acid content, as a marker for CPS, was 0.3% (E. coli 019), 4.5% (Ol), 3.9% (02ab), 1.8% (02ac), 1.7% (03), 9.5% (04), 2.7% (05), 4.4% (07) and 10.7% (012) of the LPS dry weight. The glucuronic acid content of LPS preparations from non-capsulate organisms (01, 02ab and 02ac) was, at first sight, surprising, but may possibly be explained by the presence of CPS precursor molecules in the outer membrane of these organisms.
Specijkity and antibody titres of antisera
Before absorption, ELISA titres of individual rabbit antisera against the homologous antigens ranged from 6400 (02ab) to > 102400 (01). However, there were various cross reactions, in particular between antigens 0 1-05. After cross-absorption, ELISA titres against homologous 0 antigens were a 1600, whereas titres against heterologous 0 antigens were < 100. Crossabsorptions were not performed for sera 7380 (02ab) and 5053 (02ac) to avoid removal of specific antibodies against the "2a" epitope. Furthermore, although the antiserum to strain Friedlhder 201 (01) could be fully absorbed with strain 7380 (02ab) without loss of specific activity, absorption of serum 7380 (02ab) with strain Friedlander 201 resulted in complete loss of activity against LPS 02ab. Therefore, it was concluded that the correct antigenic formula of strain Friedlhder 201 was 01/2ab, and serum 02ab was used without previous absorption with strains 5053 and Friedlhder 201.
Establishment of competitive ELISA
To reach optimal sensitivity for the detection of each individual antigen, both the amount of antibody and the concentration of LPS used for coating the microtitration plates were minimised as much as possible on the basis of chess board titrations. The final reaction conditions are summarised in Table 1. To examine the sensitivity and specificity of the inhibition reaction, antisera were mixed with increasing concentrations of homologous and heterologous LPS. Examples of the resulting inhibition curves are given in Fig. 1 . While no inhibition was seen with heterologous LPSs, homologous LPS at 0.06-1 pg/ml resulted in > 50% inhibition (Table 1) .
Concentration of LPS in bacterial supernates
The concentrations of LPS present in boiled supernates of Klebsiella strains to be tested were examined by a slightly modified version of the inhibition reaction. Antiserum against E. coli 8 188/4 1 was diluted 200-fold and allowed to react with LPS 0 1 at a coating concentration of 2 pglml. With purified LPS 0 1 as an inhibitor, a log-linear standard curve was obtained (Fig. 2a) . On the same microtitration plate, 10-fold dilutions of bacterial supernates from 19 strains previously identified as 0 1 containing an unknown ,,-\ amount of LPS were also tested. From the mean OD405
produced by these supernates at an appropriate dilution, the concentration of LPS was calculated from the standard curve. LPS concentrations ranged between 135 and 790pg/ml and were thus far above the maximum concentration of 1 pglml needed for > 50% inhibition in each of the reaction systems (Fig. 2b) . 
Confirmatory tests with additional 0-speciJic antisera
Because LPS preparations were not completely free of contaminating capsular material, it could not be excluded that capsule-mediated inhibition might occur in some instances. Therefore, confirmatory reactions were performed in those 0 serogroups for which reference strains other than the 0 antigen prototype strain were available. Thus, sera were produced against E. coli 8188/41 (019, identical with Klebsiella 01) [30] , and Klebsiella strains 2002/49 (03), Mich. 61 (04) and 5710/52 (05). Because these strains belonged to K types other than those from which the LPS preparations were made, inhibition produced with the respective sera could be assumed to be solely due to 0 antigen homology.
Typing of Klebsiella isolates
The validity of the typing method was evaluated in a pilot study of 82 clinical and laboratory Klebsiella isolates in which individual bacterial supernates were allowed to react with each of the LPS preparations and antisera available. As can be seen from the mean OD values summarised in Table 2 , reactions were usually clear-cut with OD values > 0.3 for heterologous and < 0.1 for homologous antigens. In every instance, strains identified as belonging to serogroup 0 1 on the basis of a positive inhibition reaction with serum to strain Friedlander 201 also reacted with serum to E. coli 8188/41, confirming the identity of these two 0 antigens. Fourteen of these strains also completely inhibited the reaction of serum 7380 (02ab) with LPS 02ab, thus justifylng the designation of these strains as 01/2ab. A partial inhibition of the 02ab reaction was seen with five other strains belonging to serogroup 0 1. This partial inhibition could not be explained by a reduced concentration of LPS in the samples because all of these specimens contained > 100 pg of 0 1 LPS/ml as determined by quantitative inhibition ELISA. Rather, this phenomenon appeared to be due to a less intense expression, or even absence, of the 02ab epitope in these strains.
Twenty-four isolates were identified as belonging to serogroup 02; 13 of them showed complete inhibition with antiserum 7380 (02ab) but no inhibition was seen with antiserum 5053 (02ac). It should be stressed that these two sera were not cross-absorbed with the corresponding strains in order not to remove antibodies against the '02a' component. However, the reaction pattern of the sera showed that antibodies against '02a' were lacking in serum 5053 (02ac), possibly because the 2a component was masked by the immunodominant 'c' antigen. Consequently, strains identified as 02ac on the basis of a complete inhibition reaction with serum 5053 showed only insignificant inhibition with serum 7380 (02ab).
Sixteen isolates reacted strongly with serum 2002/49 (03) and were, therefore, assigned to serogroup 03. Interestingly, none of these strains reacted with the homologous serum produced with strain 390 (03:Kll) while strain 390 itself produced complete inhibition (data not shown). At present, we have no explanation for this phenomenon although it appears possible that the 0 3 antigen reference strain (strain 390) contains more than one 0 antigen epitope, and that clinical isolates, as well as strain 2002/49, lack one of these components.
In the four strains identified as serotype 0 5 by reaction with serum 4425/51, reactions with the confirmatory serum 5710/52 were also positive. Two strains belonging to serogroup 0 7 were identified by their reaction with serum 264(1). Since no confirmatory serum was available in this case, and since LPS 0 7 contained 4.4% CPS (K67), the capsule type of these strains was examined. The two isolates belonged to capsule serotypes K32 and K47, which excludes a CPS-mediated false-positive reaction. In the material examined, no strains of serogroups 0 4 and 012 were identified, and a total of 17 strains could not be assigned to a known 0 serogroup.
The relative frequency of individual 0 groups in different Klebsiella spp. is summarised in Table 3 . The fact that all K. rhinoscleromatis strains belonged to the 02ab group is in complete accordance with the findings of Kauffmann [30] . He also examined three isolates of K. ozaenae which were found to belong to the 02ac group [30] . In this study, two K. ozaenae isolates contained the 02ab antigen and nine isolates the additional 'c' antigen (Table 3) .
Discussion
Sero-epidemiological investigations of Klebsiella 0 antigens have been hampered by technical problems associated with 0 antigen typing. While the 0 antigens of other enterobacteria are readily identified by simple slide agglutination tests [37, 38] , Klebsiella strains are often 0 inagglutinable because of the copious capsule produced by most isolates [27, 30] . Furthermore, although 0-specific antisera are usually produced by immunisation with boiled organisms, the capsular material may retain some of its immunogenicity. Thus, so-called 0-specific sera in reality are OK-sera, and agglutination reactions may be due to K antigen homology. Therefore, Kauffiann [30] and 0rskov [ 181, who identified the first Klebsiella 0 antigens, produced their antisera with acapsular mutants. Furthermore, such acapsular mutants had also to be raised from the strains to be tested to allow agglutination to take place [18, 30] .
Because isolation of acapsular mutants is both tedious and time-consuming, several investigators took advantage of the fact that Klebsiella 0 antigens are released into the medium during growth in broth. Thus, Fujita and Matsubara, with latex particles coated with 0-specific antibodies and bacterial culture supernates for agglutination, were able to identi@ the 0 antigen in 328 of 361 clinical isolates of Klebsiella [19] . Others have used bacterial supernates to inhibit type-specific prototype reactions measured by passive haemagglutination [20] or ELISA [21, 29] . However, with the exception of our own preliminary study [29] , these investigations were limited to serogroup 0 1.
In the present study, several ameliorations were made compared to previously described methods. Thus, while Alberti et al. precipitated the 0 antigen from bacterial supernates by means of the phenol-water method [21] , we found that large amounts of 0 antigen could be released simply by boiling freshly harvested bacteria. By quantitative inhibition, 135-790 pg/ml of LPS were detectable in boiled supernates of 0 1 strains. Preliminary chessboard titrations of the antisera were used to dilute specific antibodies as much as possible and to minimise the amount of antigen coated on microtitration plates. By this means, a sensitivity of at least 1 pg of homologous LPS/ml was reached in each of the systems, making the method sensitive enough to detect LPS even in cases when other supernates would contain somewhat lower amounts of LPS than the 0 1 strains tested.
In spite of the removal of CPS by cetavlon precipitation, final LPS preparations usually contained 2-5%
(in two cases > 9%) CPS as judged by the glucuronic acid method. Therefore, the possibility of K antigenbased false-positive reactions was not completely excluded, necessitating cross-checking of each inhibition reaction with confirmatory sera raised against strains of heterologous K types. Because discrepancies between primary and confirmatory reactions were not found, it must be assumed that boiling of the strains used for immunisation and, additionally, of strains to be tested, sufficiently prevented K antigen-mediated reactions. In several instances, in particular 02ab and 02ac, reference strains containing homologous 0 antigens were not available. However, since antisera against serogroups 02ab and 02ac were raised with non-capsulate strains, positive reactions in these systems may be assumed to be due to 0 antigen homology.
Several novel observations were made when the typing system was applied to clinical isolates. Firstly, although 19 isolates were identified as belonging to serogroup 01, 14 of these also reacted strongly with the 02ab serum ( Table 2 ). This contrasts with earlier studies by Kaufhann [30] and Fujita and Matsubara [19] who found a positive reaction with serum 02ab (produced with strain 7380 as in the present study) in only two of 121 strains of serogroup 0 1 [19] . However, it has been shown recently that the 0 1 antigen produced by a reference strain (01:IQO) contained two 0 antigen epitopes, identified as Dgalactan I and I1 [28] . Immunologically, D-galactan I was found to correspond to the 02a antigen [28, 39] . The present study confirms that clinical isolates of serogroup 0 1 may in fact harbour an LPS epitope indistinguishable by conventional serology from that of 02a strains, and the designation 01/2a may be appropriate for these isolates. However, although only a limited number of strains was included in this study, five 0 1 strains were identified in which the 02a epitope was only poorly expressed or absent. Our previous study has demonstrated 0 1 strains that did not contain a genus-specific common LPS epitope defined by a monoclonal antibody and otherwise expressed by most KZebsieZZa isolates [29] . Thus, the 0 1 serogroup appears to be antigenically heterogeneous, a phenomenon that has to be examined further by detailed immunochemical and molecular analyses.
Thirteen and 11 strains harboured the 02ab and 02ac antigens, respectively. Because the 02a antigen is the only true LPS antigen in strain 7380 while the 'b' antigen appkars to arise from a different cellular component [39] , the 0 serogroup of the first group of strains might also be expressed as 02a. Interestingly, although the two sera were not cross-absorbed in order not to remove 2a-specific antibodies, serum 5053 did not recognise 02a strains. Conversely, serum 7380 was inhibited only slightly by strains harbouring the 02c epitope. These findings are in complete accordance with Whitfield et aZ. who reported that the 02c antigen appeared to be associated with a longer polysaccharide chain structure than that in 02a and therefore it masks the 02a antigen in strains possessing both 0 antigen epitopes [39] .
A peculiar observation was made in the system established to detect the 0 3 antigen. Antiserum raised against the reference strain 390 (03:Kll) reacted strongly with LPS extracted from this strain, and this reaction was inhibited both by purified LPS and the boiled supernate of strain 390. However, no clinical isolate reactive in this system was detected in a first series of experiments. Later, the confirmatory serum to strain 2002/49 (03:K25) was found to react as well with LPS 390. Sixteen isolates exhibiting the 0 3 antigen were clearly identified in this system. At present, we have no ready explanation for this finding. However, since heterogeneous LPS antigens have been found in serogroups 0 1 and 02, it is possible that the serogroup 0 3 strains comprise more than one 0 antigen. The subgroup represented by the clinical isolates and strain 2002/49 might lack a partial antigen present in strain 390. This would explain the lack of inhibition of serum 390 by supernates of these isolates.
Further studies involving a larger number of 0 3 strains from clinical material are clearly warranted to clarify this issue.
Although a few isolates could be assigned to serogroups 0 5 and 07, no strains reactive with 0 4 and 012 antisera were detected. In addition, 17 (21%) of the strains could not be 0 serogrouped, a percentage considerably larger than that reported for isolates from Japan [19] . It was interesting to note that nontypable isolates occurred rather frequently in the newly described species K. terrigena [33] . Further studies involving a larger number of isolates and including additional sera raised against non-typable strains will have to clarify whether other, hitherto unrecognised, 0
antigens may play a role. Also, such studies that are currently under way in our laboratory will have to relate the expression of certain 0 antigens to the clinical disease state, thus allowing an assessment of the pathogenic potential of individual 0 antigens for the manifestation of invasive klebsiella infection.
